NEW YORK (TheStreet) -- CHANGE IN RATINGS

Arris

(ARRS) - Get Report

upgraded at UBS from Neutral to Buy. $13 price target. Valuation call, given the company's low multiple.

BB&T

(BBT) - Get Report

upgraded at Credit Suisse to Neutral from Underperform as growth will exceed peers over next few quarters. 2009 and 2010 EPS estimates raised to $1 and $1.15, respectively. Price target lifted by 3 dollars to $31.

Dole Food

(DOLE)

rated new Neutral at Goldman. $15 price target. Near-term results could be challenging, but the company should be able to post gradual growth.

Dreamworks Animation

(DWA)

upgraded at Janney Montgomery from Neutral to Buy. $45 price target. Stock is down from its highs, but 2010 prospects are improving.

FMC Technologies

(FTI) - Get Report

rated new Buy at Citigroup. $66 price target. Company is a leader in subsea equipment, and should be able to capture more large-scale projects in the coming years.

KB Home

(KBH) - Get Report

upgraded at Credit Suisse to Outperform from Neutral on order growth and valuation. 2009 and 2010 EPS estimates introduced at -$3.35 and -$0.75, respectively. Price target raised by a dollar to $18.

Lifepoint Hospitals

(LPNT)

rated new Overweight at Morgan Stanley. $33 price target. Company should outperform its peers, even though industry pricing should become more competitive in 2011.

M.D.C. Holdings

(MDC) - Get Report

upgraded at Credit Suisse to Neutral from Underweight on strong balance sheet and land opportunities. 2009 and 2010 EPS estimates introduced at -$2.85 and -$1.35, respectively. Price target lifted to $29 from $26.

Pepco Holdings

(POM)

downgraded at Credit Suisse to Neutral from Outperform on valuation. 2009 and 2010 EPS estimates tweaked to $0.95 and $1.32, respectively. Maintain $16 price target.

RF Micro Devices

(RFMD)

upgraded at UBS from Neutral to Buy. $5.50 price target. Company paid down debt and cash flow is improving. End-markets also appear to be improving.

SunTrust Banks

(STI) - Get Report

upgraded at Credit Suisse to Outperform from Neutral on earlier recovery. 2009 and 2010 EPS estimates set at -$4.52 and -$1.55, respectively. Price target raised to $29 from $23.

Constellation Brands

(STZ) - Get Report

downgraded at Goldman from Neutral to Sell. $16 price target. Wine results could fall short of expectations.

Solarwinds

(SWI) - Get Report

rated new Buy at Needham. Coverage of SWI was started with a Buy rating. $24 price target. Company should be able to sustain 25% annual organic sales growth.

Sysco

(SYY) - Get Report

upgraded at BB&T from Hold to Buy. $34 price target. Company should be able to exceed near-term expectations.

STOCK COMMENTS / EPS CHANGES

Accenture

(ACN) - Get Report

price target raised at Credit Suisse to $55 from $42 as the company is starting recovery. 2010 and 2011 EPS estimates set at $2.68 and $3.06, respectively. Outperform rating.

Amazon.com

(AMZN) - Get Report

estimates, target increased at FBR. Shares of AMZN now seen reaching $160. Estimates were also raised, to reflect market share gains. Outperform rating.

Bemis

(BMS) - Get Report

added to Top Picks Live list at Citigroup. Estimates also boosted, as the AL packaging deal should create significant value. Buy rating and new $36 price target.

CH Robinson

(CHRW) - Get Report

estimates lowered at Morgan Stanley through 2011. Gross margins continue to fall. Equal-weight rating.

Covance

(CVD)

estimate cut at Barclays. CVD 2010 EPS estimate lowered to $3.00 from $3.18. Maintain Equal Weight rating and $47 price target.

Express Scripts

(ESRX)

estimates, target raised at Goldman. Target was increased to $105. Estimates also boosted, to reflect synergies from the NextRx deal. Buy rating.

Fairchild Semiconductor

(FCS)

numbers boosted at FBR. Shares of FCS now seen reaching $16. Estimates also raised, to reflect the company's new guidance. Outperform rating.

Forest Oil

(FST)

price target boosted at Credit Suisse to $26 from $22. 2009 EPS estimate raised to $1.94, 2010 lowered to $1.66. Outperform rating.

Gilead Sciences

(GILD) - Get Report

numbers raised at UBS. Shares now seen reaching $66. Estimates also boosted, to reflect new government HIV treatment guidelines. Buy rating.

Sirona Dental Systems

(SIRO)

target, estimate higher at Barclays. Barclays raised SIRO price target to $30 from $26. 2009 EPS maintained at $1.72, 2010 lifted to $1.92. Equal Weight rating.

Staples

(SPLS)

target, estimates raised at Credit Suisse. SPLS price target increased to $29 from $26. 2010 EPS estimate raised to $1.13, 2011 maintained at $1.38. Reiterate Outperform rating.

Staples

(SPLS)

estimates, target raised at Goldman. Shares of SPLS now seen reaching $27. Estimates also boosted, as the company's operating margin appears to have bottomed out. Buy rating.

Staples

(SPLS)

target boosted at FBR. Shares seen reaching $20. Retail sales are improving and the stock deserves a market multiple. Underperform rating.

UnitedHealth Group

(UNH) - Get Report

estimate lower at Barclays. Barclays trimmed UNH 2010 EPS estimate by 10 cents to $3.15, 2009 maintained at $3.18. Reiterate Overweight rating and $33 price target.

Universal Technical Institute

(UTI) - Get Report

estimates raised at Credit Suisse. Increased UTI 2009 and 2010 EPS estimates to $0.48 and $0.92, respectively. Maintain Neutral rating and $19 price target.

Dentsply International

(XRAY) - Get Report

price target cut at Barclays. XRAY price target lowered by a dollar to $36. Maintain 2009 and 2010 EPS estimates at $1.85 and $2.08, respectively. Overweight rating.

Zions Bancorporation

(ZION) - Get Report

numbers cut at FBR. Shares of ZION now seen reaching $19. Estimates also reduced, to reflect lower expected fee income and a smaller net interest margin. Outperform rating.

This article was written by a staff member of TheStreet.com.